Other studies have suggested significant disparities in the presentation of BC in Hispanic women in the United States compared to other groups related to more adverse prognosis, and increased prevalence of estrogen receptor and progesterone receptor (ER/PR)‐negative disease 8, 9, 10. This evidence concerns the gene ESR1 and breast cancer.